Springer Protocols: Abstract: Isolation and Culturing of Human Vascular Smooth Muscle Cells

Isolation and Culturing of Human Vascular Smooth Muscle Cells

By: Finnbogi R. Thormodsson², Ingvar H. Olafsson³

Abstract

Full Text

Download PDF (2999K)

Cerebral amyloid angiopathy (CAA) results from amyloid accumulation within arteries of the cerebral cortex and leptomeninges. This condition is age-related, especially prevalent in Alz-heimer' disease (AD), and the main feature of certain hereditary disorders (i.e., HCHWA-I). The vascular smooth muscle cells (VSMCs) appear to play a vital role in the development of CAA, which makes them well-suited as an experimental model to study the disease and screen for possible remedies. We describe two different methods for isolating and culturing human VSMCs. First, using the human umbilical cord as an easy source of robust cells, and secondly, using brain tissue that provides the proper cerebral VSMCs, but is more problematic to work with. Finally the maintenance, preservation, and characterization of the isolated VSMCs are described.

Affiliation(s): (2) Faculty of Medicine, University of Iceland, Reykjavik, Iceland
(3) Karolinska Institute and University Hospital, Stockholm, Sweden

Book Title: Amyloid Proteins: Methods and Protocols

Series: Methods in Molecular Biology | Volume: 299 | Pub. Date: Dec-28-2004 | Page Range: 197-210 | DOI: 10.1385/1-59259-874-9:197

Subject: Protein Science

Key Words: Amyloid - cell culture - human - cystatin C - vascular smooth muscle - vascular - smooth muscle cells (VSMC) - umbilical cord - cerebral amyloid angiopathy (CAA) - HCHWA-I - immunostaining - leptomeninges - cerebral blood vessels

References

Download References

1.	Vinters, H. V. (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18, 311–324.

2.	Revesz, T., Holton, J. L., Lashley, T., et al. (2002) Sporadic and familial cerebral amyloid angiopathies0. Brain Pathol. 12, 343–357.

3.	Levy, E., Carman, M. D., Fernandez-Madrid, I. J., et al. (1990) Mutation of the Alzheimer%s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124–1126.

4.	Gudmundsson, G., Hallgrimsson, J., Jonasson, T. A., and Bjarnason, O. (1972) Hereditary cerebral haemorrhage with amyloidosis. Brain 95, 387–404.

5.	Bjarnadottir, M., Nilsson, C., Lindstrom, V., et al. (2001) The cerebral hemor-rhage-producing cystatin C variant (L68Q) in extracellular fluids. Amyloid: Int. J. Exp. Clin. Invest. 8,1–10.

6.	Wisniewski, H. M., Fraçkowiak, J., Zóltowska, A., and Kim, K. S. (1994) Vascu-lar β-amyloid in Alzheimer' disease angiopathy is produced by proliferating and deghenerating smooth muscle cells. Amyloid: Int. J. Exp. Clin. Invest. 1, 8–16.

7.	Wang, Z. Z., Jensson, O., Thorsteinsson, L., and Vinters, H. V. (1997) Microvascular degeneration in hereditary cystatin C amyloid angiopathy of the brain. Apmis 105, 41–47.

8.	Wisniewski, H. M., Frackowiak, J., and Mazur-Kolecka, B. (1995) In vitro production of ß-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neuroscience Letters 183, 120–123.

9.	Van Nostrand, W. E., Davis-Salinas, J., and Saporito-Irwin, S. M. (1996) Amyloid β-protein induces the cerebrovascular cellular pathology of Alzheimer' disease and related disorders. Ann. NY Ac ad. Sci. 777, 297–302.

10.	Mulder, A.B., Blom, N. R., Smit, J. W., et al. (1995) Basal tissue factor expression in endothelial cell cultures is caused by contaminating smooth muscle cells. Reduction by using chymotrypsin instead of collagenase. Thromb. Res. 80, 399–411.

11.	Van Nostrand, W. E., Rozemuller, A. J. M., Chung, R., Cotman, W., and Saporito-Irwin, S.M. (1994) Amyloid β-protein precursor in cultured leptomeningeal smooth muscle cells. Amyloid: Int. J. Exp. Clin. Invest. 1, 1–7.

Comments (Loading...)

Post comment/View all comments